MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bharti, A.
Right arrow Articles by Kharbanda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bharti, A.
Right arrow Articles by Kharbanda, S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 1998, p. 6719-6728, Vol. 18, No. 11
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Inactivation of DNA-Dependent Protein Kinase by Protein Kinase Cdelta : Implications for Apoptosis

Ajit Bharti,1 Stine-Kathrein Kraeft,2 Mrinal Gounder,1 Pramod Pandey,1 Shengfang Jin,3 Zhi-Min Yuan,1 Susan P. Lees-Miller,4 Ralph Weichselbaum,5 David Weaver,3 Lan Bo Chen,2 Donald Kufe,1 and Surender Kharbanda1,*

Cancer Pharmacology1 and Cancer Biology,2 Dana-Farber Cancer Institute, and Department of Microbiology and Molecular Genetics,3 Harvard Medical School, Boston, Massachusetts 02115; Department of Biological Sciences University of Calgary, Calgary, Alberta, Canada T2N IN44; and Department of Radiation and Cellular Oncology University of Chicago, Chicago, Illinois 606375

Received 6 April 1998/Returned for modification 2 June 1998/Accepted 28 July 1998

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Protein kinase Cdelta (PKCdelta ) is proteolytically cleaved and activated at the onset of apoptosis induced by DNA-damaging agents, tumor necrosis factor, and anti-Fas antibody. A role for PKCdelta in apoptosis is supported by the finding that overexpression of the catalytic fragment of PKCdelta (PKCdelta CF) in cells is associated with the appearance of certain characteristics of apoptosis. However, the functional relationship between PKCdelta cleavage and induction of apoptosis is unknown. The present studies demonstrate that PKCdelta associates constitutively with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). The results show that PKCdelta CF phosphorylates DNA-PKcs in vitro. Interaction of DNA-PKcs with PKCdelta CF inhibits the function of DNA-PKcs to form complexes with DNA and to phosphorylate its downstream target, p53. The results also demonstrate that cells deficient in DNA-PK are resistant to apoptosis induced by overexpressing PKCdelta CF. These findings support the hypothesis that functional interactions between PKCdelta and DNA-PK contribute to DNA damage-induced apoptosis.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The cellular response to ionizing radiation (IR) and other DNA-damaging agents includes cell cycle arrest and activation of DNA repair. In the event of irreparable DNA damage, cells respond with induction of apoptosis. Apoptosis is an ultrastructurally and biochemically distinct form of cell death that occurs in response to a variety of stimuli and is carried out by a genetically determined cell suicide program (21, 23). Cells undergoing apoptosis exhibit morphological and biochemical characteristics that include blebbing of the cell membrane, a decrease in cell volume, nuclear condensation, and internucleosomal cleavage of DNA (26, 57). However, the intracellular signals that control the induction of apoptosis are unclear.

The induction of apoptosis by a variety of stress inducers, including DNA damage, is associated with activation of aspartate-specific cysteine proteases (caspases) (1, 12, 41, 42). Direct involvement of caspases in the induction of apoptosis is supported by studies with the cowpox virus protein CrmA (48), the baculovirus protein p35 (6), and peptide inhibitors (3, 46, 47). CrmA inhibits the induction of apoptosis in cells treated with Fas ligand or tumor necrosis factor (15, 39, 53). By contrast, IR-induced apoptosis involves activation of a CrmA-insensitive pathway (10). These findings have suggested that DNA damage-induced apoptosis is conferred by signals that are distinct from those activated by Fas and tumor necrosis factor (10). The demonstration that IR induces the activation of caspase 3 and that this event, like IR-induced apoptosis, is mediated by a CrmA-insensitive, p35-sensitive pathway (10) has provided support for caspase 3 as a key effector. IR-induced activation of caspase 3 is associated with proteolytic cleavage of poly(ADP-ribose) polymerase (25, 32, 43) and other proteins. Activation of caspase 3 in irradiated cells is regulated by members of the Bcl-2/Bcl-xL family (10, 14). Bcl-2 and Bcl-xL block the release of cytochrome c from mitochondria of cells treated with IR and other agents (28, 31, 58). In this context, cytochrome c release activates caspase 9, and this event is upstream to activation of caspase 3 (36).

The protein kinase C (PKC) family of serine/threonine kinases consists of multiple isoforms that possess a conserved catalytic domain (29). Studies have demonstrated that the calcium-independent delta  isoform is cleaved in cells induced to undergo apoptosis in response to DNA-damaging agents (13, 14). PKCdelta is cleaved by caspase 3 at the third variable region (V3) to a 40-kDa catalytically active fragment (13, 14, 17). The finding that overexpression of the PKCdelta catalytic fragment (PKCdelta CF) is associated with chromatin condensation, nuclear fragmentation, appearance of sub-G1 DNA, and lethality has supported a role for PKCdelta cleavage in induction of apoptosis (17). The ubiquitously expressed PKCdelta is unique among the PKC isoforms as a substrate for tyrosine phosphorylation (36). Transformation by Ras (11) or v-Src (60) results in tyrosine phosphorylation of PKCdelta . Other studies have demonstrated that PKCdelta is phosphorylated and activated by c-Abl during the response to DNA damage (59). PKCdelta has been shown to activate the MEK-extracellular signal-regulated kinase (ERK) pathway by a mechanism dependent on Raf and independent of Ras (37). In concert with a potential tumor suppressor function (40), PKCdelta has also been linked to induction of growth arrest (16, 54) and apoptosis (17).

The DNA-dependent protein kinase (DNA-PK) is essential in the repair of DNA double-strand breaks that form in irradiated cells and in V(D)J recombination (20, 22, 55). DNA-PKcs is the 470-kDa catalytic subunit of DNA-PK that contains a protein kinase homology domain at the C terminus. DNA-PKcs activity is induced by binding to the 70- and 80-kDa Ku heterodimer (2, 33). Ku binds to DNA in double-strand break repair reactions and thereby recruits DNA-PKcs to sites of DNA damage (5, 34, 50). Recent studies have demonstrated that DNA-PKcs is a self-contained kinase that is activated by direct interaction with double-stranded DNA and that the role of Ku is to stabilize the binding of DNA-PKcs to DNA ends (9, 18). DNA-PKcs, but not Ku, is cleaved by caspase-3 during apoptosis (7, 19, 51). The available evidence indicates that DNA-PKcs is cleaved into 240-, 150-, and 120-kDa fragments and that cleavage is associated with loss of DNA-PK activity (51). The 240-kDa fragment is derived from the N terminus, and the 150-kDa fragment, which contains the kinase homology domain, is from the C terminus (51). The 150-kDa fragment can also undergo further cleavage to a 120-kDa protein that retains the kinase domain (51).

The present studies demonstrate that PKCdelta interacts with DNA-PKcs. The results show that PKCdelta CF phosphorylates the cleaved fragment of DNA-PKcs and inactivates it in vitro. Phosphorylation of DNA-PKcs by PKCdelta also inhibits the binding of DNA-PKcs to DNA. We further show that cells deficient in DNA-PK exhibit resistance to apoptosis induced by overexpressing the catalytically active form of PKCdelta .

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Cell culture. U-937 monoblastic leukemia cells (American Type Culture Collection, Rockville, Md.) were grown in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum (FBS), 100 U of penicillin per ml, 100 mg of streptomycin per ml, and 2 mM L-glutamine. The cell lines SCSV3, SCH8-1, CHO, and CHO/V-3 were cultured in Dulbecco's modified Eagle's medium containing 10% heat-inactivated FBS. Irradiation was performed at room temperature with a Gammacell-1000 (Atomic Energy of Canada, Ottawa, Ontario, Canada) under aerobic conditions with a 137Cs source emitting at a fixed-dose rate of 0.76 Gy/min as determined by dosimetry.

Immunoprecipitation and immunoblot analysis. Cell lysates and immunoprecipitations were prepared as described previously (45). Soluble proteins (150 µg) were incubated with anti-PKCdelta (Santa Cruz Biotechnology, Santa Cruz, Calif.) or anti-DNA-PK (Upstate Biotechnology, Inc., Upstate, N.Y.) for 1 h and precipitated with protein A-Sepharose for an additional 1 h. Preimmune rabbit serum (PIRS) was used as a negative control. The resulting immune complexes were washed three times with lysis buffer, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to nitrocellulose filters. Total-cell lysate (30 µg) was used as a positive control. The residual binding sites were blocked by incubating the nitrocellulose paper in 5% dry milk in phosphate-buffered saline (PBS)-0.05% Tween 20 for 1 h at room temperature and then with anti-PKCdelta or anti-DNA-PK antibodies for 1 h. The antigen-antibody complexes were visualized by enhanced chemiluminescence (ECL detection system; Amersham). Signal intensities were determined by densitometric analysis (UltroScan; LKB, Bromma, Sweden).

Far-Western analysis. Purified DNA-PK protein (1 µg; provided by S. P. Lees-Miller) was subjected to SDS-PAGE and transferred to a nitrocellulose filter. Three identical filters were made. The filters were then incubated with purified glutathione S-transferase (GST)-full-length PKCdelta (PKCdelta FL), GST-PKCdelta CF, or GST for 1 h at room temperature. The filters were then analyzed by immunoblotting with anti-PKCdelta .

Generation of expression constructs. FL, CF, and kinase-inactive (CF K-R) PKC were prepared by cloning the appropriate PCR product of human PKCdelta into pGEX-2T (Pharmacia Biotech, Uppsala, Sweden). The resultant plasmids, pGEX-PKCdelta FL, pGEX-PKCdelta CF, and pGEX-PKCdelta CF K-R contain a tac promoter controlling the expression of a fusion protein consisting of GST linked to the N terminus of human PKCdelta FL or CF. A similar strategy was used for green fluorescence protein (GFP) fusion constructs by cloning the PCR product of PKCdelta into a eukaryotic expression vector, pEGFP-c1 (Clontech, Palo Alto, Calif.). The resultant plasmids, pEGFP-PKCdelta CF and pEGFP-PKCdelta CF K-R, contain the cytomegalovirus promoter controlling the expression of a fusion protein consisting of GFP linked to the N terminus of PKCdelta CF.

Dissociation of DNA-PKcs from DNA by PKCdelta . DNA-PK/Ku (1 µg; Promega) was incubated with double-stranded DNA-cellulose (15 µg; Sigma) in kinase buffer (25 mM HEPES [pH 7.4], 75 mM KCl, 10 mM MgCl2, 1 mM dithiothreitol [DTT], 0.2 mM EGTA, 0.1 mM EDTA) for 30 min at room temperature. The DNA-cellulose beads were then washed and resuspended in kinase buffer. The kinase reaction mixtures containing beads, 100 µM ATP, and GST-PKCdelta CF or GST-PKCdelta CF K-R were incubated for 15 min at 30°C. To ensure that phosphorylation was not due to DNA-PKcs, wortmannin was added to inhibit DNA-PKcs activity (27). The supernatant fraction was obtained by sedimentation of the beads. After the beads were washed with kinase buffer, they and the supernatant fraction were boiled in SDS sample buffer. The proteins were separated by SDS-PAGE (5% polyacrylamide) and analyzed by immunoblotting with anti-DNA-PK.

In vitro phosphorylation of DNA-PKcs by PKCdelta . The recombinant GST-PKCdelta CF or GST-PKCdelta CF K-R linked to glutathione beads was resuspended in kinase buffer II (KBII) (20 mM Tris-HCl [pH 7.4], [gamma -32P]ATP, 20 mM MgCl2, 4 mM DTT). Purified DNA-PK (0.5 µg) in the absence of sonicated DNA was incubated in kinase buffer containing [gamma -32P]ATP with GST-PKCdelta CF or GST-PKCdelta CF K-R at 30°C for 20 min. The reaction was terminated by the addition of SDS-PAGE sample buffer (100 mM Tris-HCl [pH 7.0], 4% SDS, 720 nM 2-mercaptoethanol, 5 mg of bromophenol blue per ml), and the reaction products were analyzed by SDS-PAGE and autoradiography.

In vitro transcription-translation of DNA-PKcs fragments. Specific DNA-PKcs polypeptides were formed by using a coupled in vitro transcription-translation method (Promega) with templates generated from the cDNA by PCR as described previously (24).

DNA-PKcs polypeptide binding assays. PKCdelta CF binding to in vitro-translated DNA-PKcs polypeptides was tested by incubating GST-PKCdelta CF (5 µg) in 20 µl of MB (10 mM Tris [pH 7.4], 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 1 µg of leupeptin per ml, 1 µg of pepstatin per ml, 1 µg of aprotinin per ml) with equal amounts of each [35S]DNA-PKcs in vitro-translated product for 1 to 2 h at 4°C. A separate incubation of the in vitro-translated [35S]DNA-PKcs product with GST was used as a negative control. The beads were washed four times in 1 ml of MB at 4°C, and the proteins were eluted by boiling in SDS sample buffer. The samples were analyzed by SDS-PAGE and autoradiography. Signal intensities were determined by densitometric analysis.

Proteolysis of DNA-PKcs in vitro. Purified DNA-PKcs (1 µg) was incubated with 2.5 µg of purified recombinant caspase-3 per ml in CB (50 mM HEPES [pH 7.5], 10% glycerol, 2.5 mM DTT, 0.24 mM EDTA) at room temperature. The reaction products were analyzed by SDS-PAGE (7.5% polyacrylamide), transferred to nitrocellulose membranes, and immunoblotted with anti-DNA-PKcs.

Inactivation of the proteolytic fragment of DNA-PKcs by phosphorylation with PKCdelta CF. Purified DNA-PKcs was incubated with or without 2.5 µg of purified recombinant caspase 3 per ml in CB at room temperature for 30 min to 1 h as described above. An aliquot was saved for immunoblotting with anti-DNA-PKcs. The cleaved fragments of DNA-PKcs were mixed with purified GST-PKCdelta CF or GST-PKCdelta CF K-R linked to GST-beads and further incubated for 15 min at 30°C in KB containing [gamma 32P]ATP. The GST-PKCdelta CF and GST-PKCdelta CF K-R were then removed by sedimentation to avoid substrate phosphorylation by PKCdelta CF in the next kinase reaction. The supernatants containing the phosphorylated DNA-PKcs fragments were then incubated for an additional 15 min at 30°C with GST-p53 in KBII containing [gamma -32P]ATP. The kinase reactions were stopped by boiling in 2× SDS sample buffer. The eluted proteins were analyzed by SDS-PAGE and autoradiography.

Transient transfections. The cells were transiently transfected with pEGFP, pEGFP-PKCdelta CF, or pEGFP-PKCdelta CF K-R in the presence of Lipofectamine (Life Technologies, Gaithersburg, Md.). After 12 to 18 h, the cells were harvested and sorted by FACscan analysis.

Confocal microscopy. The cells were grown on coverslips and transfected with GFP-PKCdelta CF or GFP-PKCdelta CF K-R. After 48 h, the cells on the coverslips were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 20 min at room temperature. They were permeabilized with 0.1% Triton X-100 and stained with 0.5 µg of 4',6-diamidino-2-phenylindole (DAPI) per ml for 10 min at room temperature. The coverslips were mounted on slides with antibleach mounting medium (Molecular Probes, Eugene, Oreg.) and viewed by confocal microscopy with an LSM410 microscope (Zeiss) equipped with an argon-krypton and a UV laser.

Cell sorting and propidium iodide staining for cells with sub-G1 DNA. At 18 h after transfection, the cells were trypsinized and washed with Dulbecco's modified Eagle's medium. GFP-positive cells were sorted in a Becton-Dickinson FACS Vantage. The GFP-positive cells were replated in the culture medium-10% heat-inactivated FBS for 40 h and then fixed with 40% ethyl alcohol for 30 min. They were washed with PBS, resuspended in 0.5 µg of propidium iodide per ml in PBS, and incubated with 50 µg of RNase per ml at 37°C for 30 min. Numbers of cells with sub-G1 DNA were assessed by FACScan analysis.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

DNA-PKcs associates with PKCdelta in vivo. Whereas IR induces the activation of PKCdelta (14), we asked if PKCdelta interacts with proteins, such as DNA-PKcs, that are involved in DNA double-strand break repair. Analysis of anti-PKCdelta immunoprecipitates with an anti-DNA-PKcs antibody demonstrated reactivity with a protein of >350 kDa (Fig. 1A). PIRS was used as a negative control of immunoprecipitation. As a positive control, analysis of anti-DNA-PKcs immunoprecipitates by immunoblotting with anti-DNA-PKcs demonstrated a similar pattern of reactivity (Fig. 1A). To evaluate the stoichiometry of the interaction between DNA-PKcs and PKCdelta , we subjected U-937 cell lysates to immunoprecipitation with anti-PKCdelta and analyzed the supernatants and precipitates by immunoblotting with anti-DNA-PKcs. Signal intensities from before and after anti-PKCdelta immunoprecipitation were compared by laser densitometric scanning. The results demonstrate that approximately 50% of DNA-PKcs is associated with PKCdelta (Fig. 1B). When anti-DNA-PKcs immunoprecipitates were analyzed by immunoblotting with anti-PKCdelta in the reciprocal experiment, the results confirmed a constitutive association of DNA-PKcs with PKCdelta (Fig. 1C). The interactions between DNA-PKcs and PKCdelta are specific, since the anti-DNA-PKcs antibody does not cross-react with PKCdelta and the anti-PKCdelta antibody does not cross-react with DNA-PKcs (Fig. 1A and C). Activation of caspase 3 in irradiated cells is associated with proteolytic cleavage of PKCdelta to an active 40-kDa fragment (hereafter termed PKCdelta CF) (14). To assess the interaction of DNA-PKcs with PKCdelta CF, U-937 cells were irradiated and harvested at different time intervals. Lysates from control and irradiated cells were subjected to immunoprecipitation with anti-DNA-PKcs. Analysis of the precipitates with anti-PKCdelta demonstrated binding between DNA-PKcs and PKCdelta CF (Fig. 1D). The finding that DNase has no effect on the coimmunoprecipitation of DNA-PKcs and PKCdelta CF indicated that the association between these proteins is not dependent on DNA binding (data not shown).


View larger version (38K):
[in this window]
[in a new window]
  		FIG. 1.   Association of DNA-PKcs and PKCdelta . (A) Lysates from U-937 cells were subjected to immunoprecipitation with anti-DNA-PK (alpha DNA-PK), PIRS or anti-PKCdelta (alpha PKCdelta ). Immunoprecipitates were analyzed by immunoblotting with anti-DNA-PKcs. Whole-cell lysate (Lysate) was used as a positive control for the immunoblot analysis. (B) Soluble proteins from U-937 cells were subjected to immunoprecipitation with anti-PKCdelta . Lysates before and after immunoprecipitation were analyzed by immunoblotting with anti-DNA-PKcs (top). The results are expressed as the mean ± standard deviation (SD) of three independent experiments (bottom). (C) U-937 cell lysates were immunoprecipitated with PIRS, anti-PKCdelta , or anti-DNA-PKcs. Immunoprecipitates were analyzed by immunoblotting with anti-PKCdelta . Lysate was used as a positive control for the immunoblotting. (D) U-937 cells were treated with 20 Gy of IR and harvested at the indicated times. Lysates were immunoprecipitated with anti-DNA-PKcs, and the precipitates were analyzed by immunoblotting with anti-PKCdelta .

DNA-PKcs binds directly to PKCdelta in vitro. To assess the interaction of DNA-PKcs with PKCdelta FL and PKCdelta CF in vitro, we incubated GST fusion proteins prepared from PKCdelta FL and PKCdelta CF with U-937 cell lysates. Analysis of the adsorbates with anti-DNA-PKcs demonstrated that whereas both PKCdelta FL and PKCdelta CF bind to DNA-PKcs, the apparent affinity of the interaction with PKCdelta CF is greater than that with PKCdelta FL (Fig. 2A). To determine whether the interaction between DNA-PKcs and PKCdelta is direct, purified DNA-PKcs was incubated separately with GST-PKCdelta FL, GST-PKCdelta CF, or GST. After being washed, the bound proteins were separated by SDS-PAGE (5% polyacrylamide) and analyzed by immunoblotting with anti-DNA-PKcs. Reactivity with anti-DNA-PKcs in the GST-PKCdelta CF and GST-PKCdelta FL, but not GST, adsorbates supported a direct interaction of DNA-PKcs with PKCdelta FL and PKCdelta CF (Fig. 2B). To further demonstrate direct interaction between DNA-PKcs and PKCdelta , purified DNA-PKcs was resolved by SDS-PAGE, transferred to a nitrocellulose filter, and renatured in aquaous buffer. After incubation with GST-PKCdelta FL, GST-PKCdelta CF, or GST, the filters were washed and probed with anti-PKCdelta . Reactivity with anti-PKCdelta at the position corresponding to DNA-PKcs confirmed the direct interaction of DNA-PKcs with PKCdelta (Fig. 2C). The absence of reactivity when the filters were incubated with GST indicated that binding of DNA-PKcs with PKCdelta is specific (Fig. 2B).


View larger version (14K):
[in this window]
[in a new window]
  		FIG. 2.   Direct interaction of DNA-PKcs with PKCdelta . (A) U-937 cell lysate was incubated with GST, GST-PKCdelta FL, or GST-PKCdelta CF. The protein adsorbates were analyzed by immunoblotting with anti-DNA-PKcs. (B) Purified DNA-PK (1 µg) was incubated with GST, GST-PKCdelta FL, or GST-PKCdelta CF. After extensive washing, the bound proteins were eluted by boiling in SDS sample buffer and analyzed by immunoblotting with anti-DNA-PK. (C) Purified DNA-PK (1 µg) was resolved by SDS-PAGE and transferred to three nitrocellulose filters. The filters were incubated with GST, GST-PKCdelta FL, or GST-PKCdelta CF for 1 h at room temperature and then analyzed by immunoblotting with anti-PKCdelta antibody.

PKCdelta CF-mediated phosphorylation of DNA-PKcs inhibits DNA-PK binding to DNA in vitro. To determine whether PKCdelta phosphorylates DNA-PK, we incubated GST-PKCdelta FL or GST-PKCdelta CF with purified DNA-PKcs in the presence of [gamma -32P]ATP. The phosphorylation reactions were carried out in the absence of DNA to inhibit DNA-PKcs autophosphorylation. Analysis of the products by autoradiography indicated that DNA-PKcs is a substrate for PKCdelta (Fig. 3A, top) PKCdelta CF is at least 40 times more active than PKCdelta FL, as determined by their phosphorylation of myelin basic protein (Fig. 3A, bottom). The present results also demonstrate approximately 10-fold more phosphorylation of DNA-PKcs by PKCdelta CF (Fig. 3A, top).


View larger version (20K):
[in this window]
[in a new window]
  		FIG. 3.   PKCdelta CF phosphorylates DNA-PKcs and releases DNA-PKcs from Ku-DNA beads. (A) GST-PKCdelta FL or GST-PKCdelta CF was incubated with purified DNA-PK-Ku complex (top) or myelin basic protein (MBP) (bottom) in the presence of [gamma -32P]ATP for 15 min at 30°C. In vitro kinase reactions were analyzed by SDS-PAGE and autoradiography. (B) Purified DNA-PK/Ku was incubated with DNA beads, and the beads were washed and suspended in kinase buffer. Kinase reaction mixtures containing beads, 20 µM wortmannin, ATP, and GST-PKCdelta CF or kinase-inactive GST-PKCdelta CF K-R were incubated for 15 min at 30°C. The supernatant fraction was obtained by sedimentation of the beads. The beads and supernatant fractions were boiled in SDS sample buffer. Proteins were separated by SDS-PAGE (5% polyacrylamide) and analyzed by immunoblotting with anti-DNA-PKcs.

Recent studies have demonstrated that c-Abl-mediated phosphorylation of DNA-PK on tyrosine inhibits DNA-PKcs activity (27). Other studies have shown that autophosphorylation of DNA-PKcs inhibits its activity by inducing the dissociation of DNA-PKcs from DNA (8). To further assess the functional significance of the interaction between DNA-PKcs and PKCdelta , we asked if PKCdelta affects the association of DNA-PKcs with DNA. To address this issue, DNA-PKcs was bound to DNA-beads and incubated in the presence of wortmannin to inhibit DNA-PKcs autophosphorylation and hence its autodissociation from DNA. After being washed to remove unbound DNA-PKcs, the beads were incubated with GST-PKCdelta CF or GST-PKCdelta CF K-R in the presence of [32P]ATP. The bound and supernatant fractions were then analyzed by immunoblotting with anti-DNA-PKcs. The results demonstrate that addition of GST-PKCdelta CF K-R has no detectable effect on the release of DNA-PKcs from DNA (Fig. 3B). By contrast, incubation with GST-PKCdelta CF resulted in the release of DNA-PKcs from the beads (Fig. 3B). Whereas DNA-PK requires DNA for activity, these results suggest that PKCdelta CF inhibits DNA-PK activity by abrogating the ability of DNA-PK to associate with DNA.

PKCdelta CF binds to DNA-PKcs at its catalytic domain. To determine the regions of DNA-PKcs responsible for the association with PKCdelta CF, fragments of the DNA-PKcs polypeptide were generated from mouse DNA-PKcs cDNAs. Fourteen different DNA-PKcs fragments, representing the entire open reading frame, were synthesized by in vitro transcription-translation (Fig. 4A) (24). Purified GST-PKCdelta CF was incubated separately with the in vitro-translated fragments of DNA-PK, washed, and analyzed by autoradiography. The signal intensities of GST-PKCdelta CF-bound DNA-PKcs fragments were compared to the total amount of product in the reaction mixture by densitometeric scanning. The results demonstrate that DNA-PKcs-6 (amino acids 2333 to 2774; 10 to 15% bound to PKCdelta CF), DNA-PKcs-8 (amino acids 3414 to 3850; 12 to 18% bound), DNA-PKcs-9 (amino acids 3757 to 4124; 22 to 25% bound), and DNA-PKcs-15 (amino acids 3414 to 4123; 18 to 25% bound) associate with GST-PKCdelta CF but not with GST (Figs. 4B and C and data not shown). Thus, PKCdelta CF binds to DNA-PKcs through a 1,790-amino-acid region that in part includes the PK homology domain.


View larger version (31K):
[in this window]
[in a new window]
  		FIG. 4.   Association of PKCdelta CF with specific DNA-PKcs protein fragments. (A) Positions of the DNA-PKcs protein fragments. Protein fragments from various regions of the DNA-PKcs gene were prepared by PCR and in vitro transcription-translation as described in the text. (B) GST-PKCdelta CF bound to glutathione-Sepharose was mixed with in vitro-translated products from DNA-PKcs regions to allow binding. After being washed, samples were separated by SDS-PAGE (10% polyacrylamide) and analyzed by autoradiography. (C) GST-PKCdelta CF or GST bound to glutathione-Sepharose was mixed with DNA-PKcs fragment 6, 8, or 9. After being washed, the bound proteins were analyzed by SDS-PAGE and autoradiography.

Cleavage of DNA-PKcs by caspase 3 and inhibition of DNA-PKcs activity by phosphorylation with PKCdelta CF. Recent studies have shown that DNA-PKcs kinase activity is reduced in apoptotic cells and that the inhibition correlates with proteolytic cleavage of DNA-PKcs (51). To investigate which protease is responsible for cleaving DNA-PKcs in vitro, we treated purified DNA-PKcs with caspase 3 or interleukin-converting enzyme (ICE). In contrast to ICE, caspase 3 induced the cleavage of purified DNA-PKcs to 240- and 150-kDa fragments (Fig. 5A). Overexposed gels demonstrate a minor cleaved fragment of 120 kDa (data not shown). To determine whether cleavage of DNA-PKcs by caspase 3 inhibits DNA-PKcs activity in vitro, we incubated purified DNA-PK-Ku-DNA complexes with caspase 3 for 30 min to 1 h and used autoradiography to analyze the products of a kinase reaction performed in the presence of [gamma -32P]ATP. As assessed by autophosphorylation and/or phosphorylation of the cleaved fragments, the results demonstrate that the 240-kDa cleavage fragment of DNA-PKcs (DNA-PK CL1) is phosphorylated (Fig. 5B). In vitro, DNA-PKcs phosphorylates p53, and this event requires binding of DNA-PKcs to DNA (35). Therefore, to further assess the effect of caspase 3-mediated cleavage on DNA-PK activity, we incubated purified DNA-PK-Ku-DNA complexes with caspase 3 and assessed DNA-PK activity with GST-p53 as a substrate. The results demonstrate that cleavage of DNA-PKcs by caspase 3 inhibits in part the DNA-PKcs activity as assessed by its phosphorylation of p53 (Fig. 5C).


View larger version (28K):
[in this window]
[in a new window]
  		FIG. 5.   Caspase 3 cleaves DNA-PKcs and partially inhibits DNA-PKcs activity. (A) Purified DNA-PK was incubated with recombinant caspase 3 (2.5 µg/ml) (left) or with recombinant ICE (right) at room temperature for 1 h or 30 min, respectively. The reaction products were subjected to SDS-PAGE and analyzed by immunoblotting with anti-DNA-PKcs. (B and C) Purified DNA-PK/Ku in the presence of DNA-beads was incubated with recombinant caspase 3 for 1 h at room temperature. In vitro kinase reactions containing [gamma -32P]ATP were performed in the absence (B) or presence (C) of GST-p53 as the substrate. The reactions were stopped by the addition of SDS sample buffer, and the products were analyzed by SDS-PAGE and autoradiography. DNA-PK CL1 and CL2, DNA-PK-cleaved fragments 1 and 2.

Whereas the present findings demonstrate that cleavage of DNA-PKcs by caspase 3 is associated with partial inhibition of DNA-PKcs activity, we asked whether the cleaved DNA-PKcs fragment is affected by PKCdelta CF phosphorylation. To address this issue, we first incubated purified DNA-PK-Ku complexes with in vitro-translated caspase 3 to generate its fragments. The cleaved fragments of DNA-PKcs were then incubated with GST-PKCdelta CF, GST-PKCdelta CF K-R, or buffer in the presence of [gamma -32P]ATP. The DNA-PKcs activity in kinase reaction mixtures was assessed by autophosphorylation or phosphorylation of the DNA-PK CL1 or by using GST-p53 as the substrate. The results demonstrate that autophosphorylation of DNA-PKcs, phosphorylation of the DNA-PKcs CL1, or phosphorylation of p53 by PKCdelta CF is associated with inhibition of DNA-PKcs activity (Fig. 6). PKCdelta CF binds to DNA-PKcs at the catalytic domain (fragments 8, 9, and 15 [Fig. 4]), and this interaction contributes in part to the inhibition of DNA-PKcs (Fig. 6C). Similarly, cleavage of DNA-PKcs by caspase 3 also partially inhibits DNA-PKcs activity (Fig. 5). However, more pronounced inhibition of DNA-PKcs activity was observed upon PKCdelta CF-mediated phosphorylation of DNA-PKcs (Fig. 6C). To assess whether cleavage of DNA-PKcs facilitates the inhibition of DNA-PKcs activity by PKCdelta CF-mediated phosphorylation, we performed experiments in which uncleaved DNA-PKcs was incubated with PKCdelta CF or PKCdelta CF K-R and then analyzed for DNA-PKcs-dependent p53 phosphorylation. The results demonstrate that phosphorylation of uncleaved DNA-PKcs by PKCdelta CF inhibits DNA-PKcs activity but not to the extent observed when cleaved DNA-PKcs is phosphorylated by PKCdelta CF (Fig. 6C and data not shown). Taken together, these findings indicate that the interaction of PKCdelta CF with DNA-PKcs and caspase 3-mediated cleavage of DNA-PKcs independently contribute in part to inhibition of DNA-PKcs activity. However, nearly complete inhibition of DNA-PKcs activity was observed when PKCdelta CF phosphorylated the cleaved fragment of DNA-PKcs (Fig. 5 and 6).


View larger version (30K):
[in this window]
[in a new window]
  		FIG. 6.   Phosphorylation and inactivation of DNA-PKcs by PKCdelta CF. (A and B) Purified DNA-PK-Ku in the presence of DNA-beads was incubated with recombinant caspase 3 for 1 h at room temperature. In vitro phosphorylation of the cleaved fragments of DNA-PK was then performed in the presence of [gamma -32P]ATP and GST-PKCdelta CF or GST-PKCdelta CF K-R for 15 min at 30°C. After phosphorylation of DNA-PKcs and removal of PKCdelta -CF or PKCdelta CF K-R by sedimentation, kinase reactions were performed in the absence (A) or presence (B) of GST-p53 for an additional 15 min at 30°C. The reactions were stopped by the addition of SDS sample buffer, and the products were analyzed by SDS-PAGE and autoradiography. Lanes: 1, DNA-PK-Ku with DNA; 2, DNA-PK-Ku without DNA; 3, DNA-PK-Ku with DNA and caspase 3; 4, DNA-PK-Ku with DNA caspase 3, and GST-PKCdelta CF; 5, DNA-PK-Ku with DNA, caspase 3, and GST-PKCdelta CF K-R; 6, DNA-PK-Ku with DNA and GST-PKCdelta CF; 7, GST-p53; 8, buffer with [gamma -32P]ATP. (C) The percent inhibition of DNA-PKcs-mediated GST-p53 phosphorylation is expressed as the mean ± SD of four independent experiments.

Functional role of DNA-PK-PKCdelta complexes in apoptosis. Both PKCdelta and DNA-PKcs are cleaved after apoptotic stimuli of cells (14, 51). If the cleavage and regulation of these proteins is associated with functions in apoptosis, mutant cells of DNA-PKcs may show alterations in apoptotic pathways that are dependent on PKCdelta . DNA-PK-deficient (ScSV3, scid) and DNA-PK+ (SCH8-1, scid + human DNA-PKcs) cells (5) were transiently transfected with GFP vectors expressing PKCdelta CF. After 48 h, the morphology of GFP-positive cells was analyzed. PKCdelta was found to stimulate the disintegration or shrinkage of nuclei of DNA-PK+ cells, indicative of apoptosis (Fig. 7). In striking contrast, DNA-PK-deficient cells failed to demonstrate nuclear shrinkage in response to PKCdelta CF. To confirm whether the differential response was due to DNA-PK mutations, we examined a second set of DNA-PK mutant and control Chinese hamster ovary cell lines in the same way. DNA-PK-deficient CHO V-3 cells (52) failed to form PKCdelta CF-dependent apoptosis, unlike the DNA-PK+ parental CHO cells (Fig. 8). Thus, DNA-PK is linked to apoptotic mechanisms via PKCdelta .


View larger version (54K):
[in this window]
[in a new window]
  		FIG. 7.   Transient overexpression of PKCdelta CF in SCH8-1 (DNA-PK+/+) and ScSV3 (DNA-PK-/-) cells. GFP-tagged PKCdelta CF was transiently transfected in SCH8-1 (DNA-PK+/+) and ScSV3 (DNA-PK-/-) cells. The cells were stained with DAPI, and the GFP-positive cells were analyzed by confocal microscopy. The results are shown as overlay photographs of DAPI and GFP staining. Arrows indicate apoptotic cells. Bar, 10 µm.


View larger version (56K):
[in this window]
[in a new window]
  		FIG. 8.   Transient overexpression of PKCdelta CF in DNA-PK-/- and DNA-PK+/+ CHO cells. GFP-tagged PKCdelta CF was transiently transfected in CHO (DNA-PK+/+) and CHO V-3 (DNA-PK-/-) cells. The cells were stained with DAPI, and the GFP-positive cells were analyzed by confocal microscopy. The results are shown as overlay photographs of DAPI and GFP staining. Arrows indicate apoptotic cells. Bar, 10 µm.

If phosphorylation by PKCdelta is required in apoptosis, a PKCdelta mutant protein inactivated in kinase activity would be expected to differ in its properties in the above assay. To test this, SCH8-1 and ScSV3 cells were transiently transfected with GFP vectors expressing PKCdelta CF or the kinase-inactive mutant PKCdelta CF K-R. After 48 h, the cells were sorted for GFP positivity and analyzed for sub-G1 DNA content. Approximately 60% of the cells were apoptotic when PKCdelta CF was overexpressed in DNA-PK+/+ cells, in contrast to 20% in DNA-PK-/- cells (Fig. 9). By contrast, only 10% cells were apoptotic when PKCdelta CF K-R was transfected into DNA-PK+/+ cells (Fig. 9). Taken together, these findings demonstrate that interaction of DNA-PKcs with PKCdelta CF contributes to apoptosis.


View larger version (24K):
[in this window]
[in a new window]
  		FIG. 9.   Transient overexpression of PKCdelta CF and not PKCdelta CF K-R in DNA-PK+/+ cells is associated with induction of apoptosis. GFP-tagged PKCdelta CF or PKCdelta CF K-R mutant was transiently transfected in SCH8-1 (DNA-PK+/+) (lane 1, GFP; lane 2, GFP-PKCdelta CF; lane 3, GFP-PKCdelta CF K-R) or ScSV3 (DNA-PK-/-) (lane 4, GFP; lane 5, GFP-PKCdelta CF; lane 6, GFP-PKCdelta CF K-R) cells. As controls, cells were transfected with GFP-expressing empty vector. The GFP-positive cells were sorted by FACScan analysis and analyzed for DNA content by flow cytometry. The results are expressed as the percentage (mean ± SD of three independent experiments, each performed in duplicate) of cells with sub-G1 DNA content.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Caspase-mediated proteolysis in apoptosis. In addition to PKCdelta , substrates that are activated by caspase-mediated cleavage in apoptosis include the p21-activated kinase 2 (PAK2) (49), cytosolic phospholipase A2 (56), sterol regulatory binding proteins (44), the 45-kDa subunit of DNA fragmentation factor (38), and PITSLRE kinase alpha 2-1 (4). Expression of the cleaved fragments of PKCdelta or PAK2 in cells induces certain characteristics of apoptosis (17, 49). However, the precise role of these cleaved proteins in apoptosis is unclear. By contrast, other proteins are inactivated by caspases. Previous studies have demonstrated that DNA-PKcs is a substrate of caspase 3 and that cleavage is accompanied by loss of DNA-PKcs activity (7, 19, 51). The functional role of DNA-PK cleavage in the induction of apoptosis, like that for many of the other substrates of caspases, is unknown.

DNA-PKcs is cleaved by caspase 3 at a DEVD/N2713 site into N-terminal 240-kDa and C-terminal 150-kDa fragments. The 150-kDa fragment contains another DWVD/G site that predicts the generation of an additional fragment of 120 kDa (51). In the present studies, cleavage of DNA-PKcs to the 240- and 150-kDa fragments by caspase 3 resulted in partial loss of catalytic activity in the presence of Ku and DNA. Moreover, cleavage of DNA-PKcs also partially inhibited the DNA-PKcs-mediated phosphorylation of p53. These findings suggest that mechanisms other than cleavage of DNA-PKcs by caspase 3 are responsible for the loss of DNA-PKcs activity that has been observed in cells induced to undergo apoptosis (51).

Regulation of DNA-PKcs activity. DNA-PKcs autophosphorylation inactivates DNA-PKcs by a mechanism in which DNA-PKcs disassociates from Ku (8). Other studies have demonstrated that the c-Abl tyrosine kinase negatively regulates DNA-PKcs activity in the response to DNA damage (27). c-Abl phosphorylates the C-terminal region of DNA-PKcs and induces the disassociation of DNA-PKcs from the DNA-PKcs-Ku complex (24, 27). c-Abl and Ku both bind to the C terminus of DNA-PKcs near the kinase domain, and c-Abl phosphorylates the region of DNA-PKcs to which Ku binds (24). Thus, autophosphorylation and c-Abl-mediated phosphorylation regulate DNA-PKcs activity by mechanisms that oppose the activation of DNA-PKcs through binding to the Ku-DNA complex.

The present studies demonstrate that DNA-PKcs is also regulated by PKCdelta . DNA-PKcs constitutively associates with the full-length form of PKCdelta in nonapoptotic cells and with PKCdelta CF in cells induced to undergo apoptosis. The results indicate that PKCdelta , like c-Abl, binds directly to the C terminus of DNA-PKcs at the catalytic domain. PKCdelta CF phosphorylates DNA-PKcs and results in the disassociation of DNA-PKcs from DNA. These findings are in concert with the demonstration that interaction of DNA-PKcs with PKCdelta inhibits DNA-PKcs activity. Taken together with the finding that cleavage of DNA-PKcs by caspase 3 is partially sufficient to inhibit DNA-PKcs activity, the results support a model in which cleavage of PKCdelta to the catalytically active fragment results in association and phosphorylation of DNA-PKcs and thereby complete inhibition of DNA-PKcs activity. Thus, on the basis of these findings, we would propose that in addition to autophosphorylation (8) and c-Abl-mediated phosphorylation (24, 27), DNA-PKcs is downregulated by PKCdelta . To our knowledge, DNA-PKcs may be the first substrate found to be regulated by PKCdelta CF-mediated phosphorylation.

Recent studies have shown that PKCdelta associates constitutively with c-Abl (59). Activation of c-Abl by DNA damage results in c-Abl-dependent phosphorylation of PKCdelta . Also, c-Abl-mediated phosphorylation of PKCdelta results in activation of PKCdelta in vitro and in irradiated cells (59). Whereas c-Abl functions in the downregulation of DNA-PKcs by mediating direct phosphorylation of DNA-PKcs (27), it may also contribute to the interaction of PKCdelta and DNA-PKcs by activating PKCdelta . In this context, c-Abl associates with PKCdelta in a complex that includes DNA-PKcs (27, 59). The activation of PKCdelta by c-Abl in the response to DNA damage (59) thus provides a mechanism by which both c-Abl and PKCdelta can downregulate DNA-PKcs activity. Subsequent cleavage of PKCdelta to the catalytic fragment by caspase 3 would preclude further activation by a c-Abl-dependent mechanism. The constitutive activation of PKCdelta CF and thereby the phosphorylation of DNA-PKcs and/or the cleaved CL1 fragment is sufficient to inhibit disassociation of DNA-PKcs from the Ku-DNA complex.

Functional interaction of DNA-PKcs and PKCdelta in apoptosis. Overexpression of PKCdelta CF in cells is associated with chromatin condensation, nuclear fragmentation, induction of sub-G1 DNA, and lethality (17). These findings have indicated that cleavage of PKCdelta to a kinase-active fragment by caspase 3 contributes to multiple changes that are characteristic of apoptosis. Whereas the mechanistic basis for the proapoptotic effects of PKCdelta CF are unclear, the demonstration that PKCdelta CF interacts with DNA-PKcs prompted studies on the functional significance of this interaction. Cells deficient in DNA-PKcs were transfected to express PKCdelta CF, and the findings were compared to those obtained with cells that express DNA-PK. The results obtained with ScSv3 (DNA-PK-/-) and SCH8-1 (DNA-PK+/+) cells demonstrate that PKCdelta CF-induced apoptosis is abrogated in part in DNA-PK-deficient cells. Similar results were obtained with CHO V-3 (DNA-PK-/-) and CHO (DNA-PK+/+) cells transfected to express PKCdelta CF. These findings suggest that PKCdelta CF induces apoptosis, at least in part by a DNA-PK-dependent mechanism.

The demonstration that cells deficient in DNA-PK are hypersensitive to DNA-damaging agents has supported a direct role for DNA-PKcs in DNA repair (5, 30, 34). The inhibition of DNA-PKcs by PKCdelta CF would be expected to inhibit DNA repair and thereby facilitate the DNA fragmentation that is induced in apoptosis. Thus, given that PKCdelta inhibits DNA-PKcs activity, it is not evident why DNA-PK-/- cells would be less sensitive to PKCdelta CF-induced apoptosis. One potential explanation is that the direct binding of PKCdelta CF to DNA-PKcs provides access for DNA-PKcs substrates to phosphorylation by PKCdelta CF. In this context, DNA-PKcs associates with and phosphorylates the p53 tumor suppressor and other proteins. The present experiments have not addressed whether the pools of DNA-PKcs that associate with PKCdelta are the same as those that form complexes with other proteins. However, it is conceivable that in the absence of DNA-PKcs, PKCdelta would not be positioned to interact with a protein that is central to the apoptotic response. Insights into this potential mechanism could be obtained from an analysis of other proteins associated with the PKCdelta -DNA-PKcs complex.

    ACKNOWLEDGMENTS

We thank Stephen Jackson for critical reading of the manuscript and for invaluable suggestions.

This investigation was supported by PHS grants CA75216 (S.K.) and CA55241 (D.K.) awarded by the National Cancer Institute, DHHS.

    FOOTNOTES

* Corresponding author. Mailing address: Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney St., Boston, MA 02115. Phone: (617) 632-2938. Fax: (617) 632-2934. E-mail: Surender_Kharbanda{at}MacMailGW.dfci.harvard.edu.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1. Alnemri, E. S., D. J. Livingston, D. W. Nicholson, G. Salvesen, N. A. Thornberry, W. W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell 87:171[Medline].
2. Anderson, C. W., and S. P. Lees-Miller. 1992. The nuclear serine/threonine protein kinase DNA-PK. Crit. Rev. Eukaryotic Gene Expression 2:283-314[Medline].
3. Armstrong, R. C., T. Aja, J. Xiang, S. Gaur, J. F. Krebs, K. Hoang, X. Bai, S. J. Korsmeyer, D. S. Karanewsky, L. C. Fritz, and K. J. Tomaselli. 1996. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271:16850-16855[Abstract/Free Full Text].
4. Beyaert, R., V. J. Kidd, S. Cornelis, M. Van de Craen, G. Denecker, J. M. Lahti, R. Gururajan, P. Vandenabeele, and W. Fiers. 1997. Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor. J. Biol. Chem. 272:11694-11697[Abstract/Free Full Text].
5. Boubnov, N. V., and D. T. Weaver. 1995. Scid cells are deficient in Ku and replication protein A phosphorylation by the DNA-dependent protein kinase. Mol. Cell. Biol. 15:5700-5706[Abstract].
6. Bump, N. J., M. Hackett, M. Hugunin, S. Seshagiri, K. Brady, P. Chen, C. Ferenz, S. Franklin, T. Ghayur, P. Li, P. Licari, J. Mankovich, L. Shi, A. H. Greenberg, L. K. Miller, and W. W. Wong. 1995. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269:1885-1888[Abstract/Free Full Text].
7. Casciola-Rosen, L., D. W. Nicholson, T. Chong, K. R. Rowan, N. A. Thornberry, D. K. Miller, and A. Rosen. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1957-1964[Abstract/Free Full Text].
8. Chan, D. W., and S. P. Lees-Miller. 1996. The DNA-dependent protein kinase is inactivated by autophosphorylation of the catalytic subunit. J. Biol. Chem. 271:8936-8941[Abstract/Free Full Text].
9. Chu, G. 1997. Double strand break repair. J. Biol. Chem. 272:24097-24100[Free Full Text].
10. Datta, R., H. Kojima, D. Banach, N. J. Bump, R. V. Talanian, E. S. Alnemri, R. R. Weichselbaum, W. W. Wong, and D. W. Kufe. 1997. Activation of a CrmA-insensitive, p35-sensitive, pathway in ionizing radiation-induced apoptosis. J. Biol. Chem. 272:1965-1969[Abstract/Free Full Text].
11. Denning, M. F., A. A. Dlugosz, D. W. Threadgill, T. Magnuson, and S. H. Yuspa. 1996. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta . J. Biol. Chem. 271:5325-5331[Abstract/Free Full Text].
12. Duan, H., K. Orth, A. M. Chinnaiyan, G. G. Poirier, C. J. Froelich, W.-W. He, and V. M. Dixit. 1996. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271:16720-16724[Abstract/Free Full Text].
13. Emoto, Y., H. Kisaki, Y. Manome, S. Kharbanda, and D. Kufe. 1996. Activation of protein kinase C delta  in human myeloid leukemia cells treated with 1-beta -D-arabinofuranosylcytosine. Blood 87:1990-1996[Abstract/Free Full Text].
14. Emoto, Y., G. Manome, G. Meinhardt, H. Kisaki, S. Kharbanda, M. Robertson, T. Ghayur, W. W. Wong, R. Kamen, R. Weichselbaum, and D. Kufe. 1995. Proteolytic activation of protein kinase Cdelta by an ICE-like protease in apoptotic cells. EMBO J. 14:6148-6156[Medline].
15. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78-81[Medline].
16. Fukumoto, S., Y. Nishizawa, M. Hosoi, H. Koyama, K. Yamakawa, S. Ohno, and H. Morii. 1997. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J. Biol. Chem. 272:13816-13822[Abstract/Free Full Text].
17. Ghayur, T., M. Hugunin, R. V. Talanian, S. Ratnofsky, C. Quinlan, Y. Emoto, P. Pandey, R. Datta, S. Kharbanda, H. Allen, R. Kamen, W. Wong, and D. Kufe. 1996. Proteolytic activation of protein kinase C delta  by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:2399-2404[Abstract/Free Full Text].
18. Hammarsten, O., and G. Chu. 1998. DNA-dependent protein kinase: DNA binding and activation in the absence of Ku. Proc. Natl. Acad. Sci. USA 95:525-530[Abstract/Free Full Text].
19. Han, Z., N. Malik, T. Carter, W. H. Reeves, J. H. Wyche, and E. A. Hendrickson. 1996. DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease. J. Biol. Chem. 271:25035-25040[Abstract/Free Full Text].
20. Hartley, K. O., D. Gell, G. C. M. Smith, H. Zhang, N. Divecha, M. A. Connelly, A. Admon, S. P. Lees-Miller, C. W. Anderson, and S. P. Jackson. 1995. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849-856[Medline].
21. Horvitz, H. R., S. Shaham, and M. O. Hengartner. 1994. The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harbor Symp. Quant. Biol. 59:377-385[Medline].
22. Jackson, S. P., and P. A. Jeggo. 1995. DNA double-strand break repair, V(D)J recombination: involvement of DNA-PK. Trends Biochem. Sci. 20:412-415[Medline].
23. Jacobson, M. D., M. Weil, and M. C. Raff. 1997. Programmed cell death in animal development. Cell 88:347-354[Medline].
24. Jin, S., S. Kharbanda, B. Mayer, D. Kufe, and D. T. Weaver. 1997. Binding of Ku and c-Abl at the kinase homology region of DNA-dependent protein kinase catalytic subunit. J. Biol. Chem. 272:24763-24766[Abstract/Free Full Text].
25. Kaufmann, S. H., S. Desnoyers, Y. Ottaviano, N. E. Davidson, and G. G. Poirier. 1993. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976-3985[Abstract/Free Full Text].
26. Kerr, J. F. R., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implication in tissue kinetics. Br. J. Cancer 26:239-257[Medline].
27. Kharbanda, S., P. Pandey, S. Jin, S. Inoue, A. Bharti, Z.-M. Yuan, R. Weichselbaum, D. Weaver, and D. Kufe. 1997. Functional interaction of DNA-PK and c-Abl in response to DNA damage. Nature 386:732-735[Medline].
28. Kharbanda, S., P. Pandey, L. Schofield, R. Roncinske, S. Israel, A. Bharti, Z.-M. Yuan, R. Weichselbaum, S. Saxena, C. Nalin, and D. Kufe. 1997. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in apoptosis. Proc. Natl. Acad. Sci. USA 94:6939-6942[Abstract/Free Full Text].
29. Kikkawa, U., A. Kishimoto, and Y. Nishizuka. 1989. The protein kinase C family: heterogeneity and its implications. Annu. Rev. Biochem. 58:31-44[Medline].
30. Kirchgessner, C. U., C. K. Patil, J. W. Evans, C. A. Cuomo, L. M. Fried, T. Carter, M. A. Oettinger, and J. M. Brown. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178-1183[Abstract/Free Full Text].
31. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136[Abstract/Free Full Text].
32. Lazebnik, Y. A., S. Cole, C. A. Cooke, W. G. Nelson, and W. C. Earnshaw. 1993. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 123:7-22[Abstract/Free Full Text].
33. Lees-Miller, S. P., Y. Chen, and C. W. Anderson. 1990. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53 and the human Ku autoantigen. Mol. Cell. Biol. 10:6472-6481[Abstract/Free Full Text].
34. Lees-Miller, S. P., R. Godbout, D. W. Chan, M. Weinfeld, R. S. I. Day, G. M. Barron, and J. Allalunis-Turner. 1995. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267:1183-1185[Abstract/Free Full Text].
35. Lees-Miller, S. P., K. Sakaguchi, S. J. Ullrich, E. Appella, and C. W. Anderson. 1992. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12:5041-5049[Abstract/Free Full Text].
36. Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemn, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489[Medline].
37. Li, W., P. Michieli, M. Alimandi, M. V. Lorenzi, Y. Wu, L. H. Wang, M. A. Heidaran, and J. H. Pierce. 1996. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells. Oncogene 13:731-737[Medline].
38. Liu, X., H. Zou, C. Slaughter, and X. Wang. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184[Medline].
39. Los, M., M. van de Craen, L. C. Penning, H. Schenk, M. Westendorp, P. A. Baeuerle, W. Droge, P. H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE-CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81-83[Medline].
40. Lu, Z., A. Hornia, Y.-W. Jiang, Q. Zang, S. Ohno, and D. A. Foster. 1997. Tumor promotion by depleting cells of protein kinase Cdelta . Mol. Cell. Biol. 17:3418-3428[Abstract].
41. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827[Medline].
42. Nicholson, D. W. 1996. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol. 14:297-301[Medline].
43. Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik, N. A. Munday, S. M. Raju, M. E. Smulson, T.-T. Yamin, V. L. Yu, and D. K. Miller. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43[Medline].
44. Pai, J. T., M. S. Brown, and J. L. Goldstein. 1996. Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. USA 93:5437-5442[Abstract/Free Full Text].
45. Pandey, P., J. Raingeaud, M. Kaneki, R. Weichselbaum, R. Davis, D. Kufe, and S. Kharbanda. 1996. Activation of p38 MAP kinase by c-Abl-dependent and -independent mechanisms. J. Biol. Chem. 271:23775-23779[Abstract/Free Full Text].
46. Park, D. S., L. Stefanis, C. Y. I. Yan, S. E. Farinelli, and L. A. Greene. 1996. Ordering the cell death pathway. J. Biol. Chem. 271:21898-21905